Notes to SEFA
The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) includes the federal award activity of The Foundation for AIDS Research (“amfAR”) under programs of the federal government for the year ended September 30, 2025. The information in this Schedule is presented in accordance with Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (“Uniform Guidance”). Because the Schedule presents only a selected portion of the operations of amfAR, it is not intended to and does not present the financial position, changes in net assets or cash flows of amfAR.
The following presents a description of the Federal awards presented on the accompanying Schedule. CHIMERA The CHIMERA research training program mentors regional investigators to develop and lead implementation science research on HIV and mental health, in order to inform public health policy and improve the quality of clinical care for people living with HIV. Funding for this project is provided by grant number D43TWO11302 from the Fogarty International Center of the U.S. National Institute of Health; Federal Assistance Listing Number 93.989. The Asia-Pacific HIV Research Collaboration The Asia-Pacific HIV Research Collaboration is funded by a grant from the U.S. National Institutes of Health (“NIH”); Federal Assistance Listing Number 93.855. The collaboration seeks to examine the natural history of HIV disease and treatment outcomes in Asia, and to assess differences within Caucasian populations in Australia. Studies conducted through the Therapeutic Research Education And Treatment (“TREAT”), Asia HIC Observational Database (“TAHOD”) and the Australian HIV Observational Database (“AHOD”) seek to examine a number of questions surrounding the long-term outcomes of HIV disease, the efficacy and toxicity of antiretroviral (“ARV”) treatments in the Asia-Pacific region, and the incidence and risk factors for cancer, tuberculosis and other non-communicable diseases in people with HIV. The grant includes funds from the National Institute of Allergy and Infectious Diseases (“NIAID”) and the National Cancer Institute (“NCI”). The grant also includes funds from the National Institute of Child Health and Human Development (“NICHD”) to support the collection of data relevant to pediatric HIV/AIDS through the TREAT Asia Pediatric HIV Observational Database (“TApHOD”). TApHOD seeks to examine HIV natural history and treatment outcomes in children and adolescents in South and Southeast Asia, and to develop capacity for systematic and standardized pediatric HIV clinical data collection. Data collected with grant funds are contributed to the International Epidemiologic Database to Evaluate AIDS (“leDEA”), a global project of NIAID that includes other NIH-funded HIV cohorts in Africa, Central and South America, and North America. The Vanderbilt “Harmonist” program is an NIH-funded initiative to support data harmonization and dissemination activities for the leDEA global consortium. amfAR’s TREAT Asia program leads the Asia-Pacific component of leDEA. The City University of New York (“CUNY”) program is to represent recent and current directions in HIV policy, particularly with regard to prevention and vulnerable populations.
Nonmonetary assistance is reported in the Schedule based on the amount disbursed or received. amfAR received no nonmonetary assistance for the year ended September 30, 2025.